1. Effective antitumor activity of 5T4‐specific CAR‐T cells against ovarian cancer cells in vitro and xenotransplanted tumors in vivo. Issue 3 (22nd October 2020) Authors: Guo, Cuiyu; Dong, E; Lai, Qinhuai; Zhou, Shijie; Zhang, Guangbing; Wu, Mengdan; Yue, Xiaozhu; Tao, Yiran; Peng, Yujia; Ali, Jamel; Lu, Ying; Fu, Yuyin; Lai, Weirong; Zhang, Zhixiong; Ma, Fanxin; Yao, Yuqin; Gou, Lantu; Yang, Hanshuo; Yang, Jinliang Journal: MedComm Issue: Volume 1:Issue 3(2021) Page Start: 338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Eradication of Growth of HER2-Positive Ovarian Cancer With Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate in Mouse Xenograft Model. Issue 7 (1st September 2014) Authors: Yu, Lin; Wang, Yuxi; Yao, Yuqin; Li, Wenting; Lai, Qinhuai; Li, Jun; Zhou, Yongjun; Kang, Tairan; Xie, Yongmei; Wu, Yangping; Chen, Xiangzhen; Yi, Cheng; Gou, Lantu; Yang, Jinliang Journal: International journal of gynecological cancer Issue: Volume 24:Issue 7(2014) Page Start: 1158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer. (2nd January 2021) Authors: Yu, Lin; Lai, Qinhuai; Gou, Lantu; Feng, Jiafu; Yang, Jinliang Journal: Journal of drug targeting Issue: Volume 29:Number 1(2021) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Preparation and anti-cancer evaluation of promiximab-MMAE, an anti-CD56 antibody drug conjugate, in small cell lung cancer cell line xenograft models. (26th November 2018) Authors: Yu, Lin; Yao, Yuqin; Wang, Yuxi; Zhou, Shijie; Lai, Qinhuai; Lu, Ying; Liu, Yu; Zhang, Ruirui; Wang, Ruixue; Liu, Chuang; Gou, Lantu; Chen, Xiaoxin; Yu, Yamei; Chen, Qiang; Yang, Jinliang Journal: Journal of drug targeting Issue: Volume 26:Number 10(2018) Page Start: 905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. Issue 2 (18th January 2016) Authors: Chen, Xiangzheng; Wu, Yangping; Yang, Tinghan; Wei, Mingtian; Wang, Yuxi; Deng, Xiangbing; Shen, Congcong; Li, Wenting; Zhang, Hang; Xu, Weiyong; Gou, Lantu; Zeng, Yong; Zhang, Yonghui; Wang, Ziqiang; Yang, Jinliang Journal: Journal of cachexia, sarcopenia and muscle Issue: Volume 7:Issue 2(2016) Page Start: 225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Targeting of DDR1 with antibody‐drug conjugates has antitumor effects in a mouse model of colon carcinoma. Issue 9 (22nd July 2019) Authors: Tao, Yiran; Wang, Ruixue; Lai, Qinhuai; Wu, Mengdan; Wang, Yuxi; Jiang, Xiaohua; Zeng, Lishi; Zhou, Shijie; Li, Zhongping; Yang, Tinghan; Yao, Yuqin; Wu, Yangping; Yu, Lin; Fu, Yuyin; Lai, Weirong; Peng, Yujia; Lu, Ying; Zhang, Zhixiong; Guo, Cuiyu; Zhang, Guangbing Journal: Molecular oncology Issue: Volume 13:Issue 9(2019) Page Start: 1855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. What can proteomics teach us about bone marrow aging?. (December 2010) Authors: Wang, Wei; Gou, Lantu; Yang, Jinliang Journal: Expert review of proteomics Issue: Volume 7:Number 6(2010) Page Start: 799 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗